Cargando…
Activity of a novel antimicrobial peptide against Pseudomonas aeruginosa biofilms
With the increasing recognition of biofilms in human disease, the development of novel antimicrobial therapies is of critical importance. For example, in patients with cystic fibrosis (CF), the acquisition of host-adapted, chronic Pseudomonas aeruginosa infection is associated with a decline in lung...
Autores principales: | Beaudoin, Trevor, Stone, Tracy A., Glibowicka, Miroslawa, Adams, Christina, Yau, Yvonne, Ahmadi, Saumel, Bear, Christine E., Grasemann, Hartmut, Waters, Valerie, Deber, Charles M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6170476/ https://www.ncbi.nlm.nih.gov/pubmed/30283025 http://dx.doi.org/10.1038/s41598-018-33016-7 |
Ejemplares similares
-
Staphylococcus aureus interaction with Pseudomonas aeruginosa biofilm enhances tobramycin resistance
por: Beaudoin, T., et al.
Publicado: (2017) -
The role of Psl in the failure to eradicate Pseudomonas aeruginosa biofilms in children with cystic fibrosis
por: Morris, Amanda J., et al.
Publicado: (2021) -
Approaches to Targeting Bacterial Biofilms in Cystic Fibrosis Airways
por: Martin, Isaac, et al.
Publicado: (2021) -
Evaluation of digital dispense-assisted broth microdilution antimicrobial susceptibility testing for Pseudomonas aeruginosa isolates
por: Clark, Shawn T., et al.
Publicado: (2021) -
Anti-Infectives Restore ORKAMBI(®) Rescue of F508del-CFTR Function in Human Bronchial Epithelial Cells Infected with Clinical Strains of P. aeruginosa
por: Laselva, Onofrio, et al.
Publicado: (2020)